Showing results (311-320 of 369) with videos related to
Sort By:
Pageof 37
Clinical Endocrinology|February 1, 1977
Lung tumours and ACTH productionG A Bloomfield, I M Holdaway, B Corrin, et al.Neuroendocrinology|January 1, 1984
Regional distribution of pro-opiomelanocortin-derived peptides in the human brainP C Emson, R Corder, S J Ratter, et al.British Journal of Obstetrics and Gynaecology|September 1, 1990
The rate of rise of corticotrophin releasing factor and endogenous digoxin-like immunoreactivity in normal and abnormal pregnancyC D Wolfe, A Petruckevitch, R Quartero, et al.Clinical Endocrinology|January 1, 1987
Growth hormone pretreatment in man blocks the response to growth hormone-releasing hormone; evidence for a direct effect of growth hormoneR J Ross, F Borges, A Grossman, et al.Clinical Endocrinology|March 1, 1980
Immunoreactive somatostatin changes during insulin-induced hypoglycaemia and operative stress in manJ A Wass, E Penman, S Medbak, et al.Gut|November 1, 1984
Does gastric acid release plasma somatostatin in man?M R Lucey, J A Wass, P D Fairclough, et al.Clinical Nephrology|December 1, 1983
Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysisJ W Muir, G M Besser, C R Edwards, et al.The Journal of Endocrinology|April 1, 1987
A phaeochromocytoma presenting with Cushing's syndrome associated with increased concentrations of circulating corticotrophin-releasing factorD S Jessop, D Cunnah, J G Millar, et al.Clinical Endocrinology|June 1, 1979
Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndromeA Gomez-Pan, M F Scanlon, M O Thorner, et al.British Journal of Cancer|January 1, 1992
Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronideD Hucks, P I Thompson, L McLoughlin, et al.Pageof 37